Roche’s Vabysmo Grabs Top Growth Spot As Sales Decline

Retreats From MAGE-A4 Bispecifics

 
• By Ayisha Sharma
  
Blue eyes with eye lashes
Vabysmo Could Challenge Eylea and Lucentis With Label Expansions • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business